New York, NY – (USAStockReport) – 2/24/2013 – Synovus Financial Corp.(NYSE:SNV) closed up by 1.98% at $2.57 after trading nearly 7 million shares. The company provides financial services such as commercial and retail banking, investment and mortgage services and has $27 billion in assets. Last week, Fitch Ratings affirmed the long-term and short-term Issuer Default Ratings (IDRs) of Synovus Financial Corp. (SNV) and its subsidiaries at ‘BB-/B’. The outlook has been revised to Positive from Negative.
Is SNV a solid investment at these levels? Find out here.
Keryx Biopharmaceuticals (NASDAQ:KERX) rose 2.45% to close at $6.70 on rather low volume of 2.2 million shares compared with average daily volume of about 13 million shares. The company announced that Ron Bentsur, the Company’s Chief Executive Officer, will be presenting at the Citigroup 2013 Global Healthcare Conference, being held February 25-27, 2013, in New York City. Keryx focuses on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease.
How Should Investors Trade KERX Now? Find out here.
Generex Biotechnology Corporation (PINK:GNBT) fell by 1.72% and closed at $0.0343 with investors exchanging 2.2 million shares during the day. Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity without any deposits in the lungs. The company trades at a market cap of nearly $13 million. Its earning release for Q2 2013 is scheduled for March 11, 2013, and a shareholder meeting will be held on March 28, 2013.
How Should Investors React To GRPN Now? Find out here.